Does DOXAZOSIN Cause Salivary hypersecretion? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Salivary hypersecretion have been filed in association with DOXAZOSIN (Doxazosin). This represents 0.3% of all adverse event reports for DOXAZOSIN.
16
Reports of Salivary hypersecretion with DOXAZOSIN
0.3%
of all DOXAZOSIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From DOXAZOSIN?
Of the 16 reports, 1 (6.3%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXAZOSIN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does DOXAZOSIN Cause?
Asthma (413)
Dyspnoea (393)
Hypotension (385)
Drug ineffective (367)
Productive cough (350)
Syncope (343)
Dizziness (341)
Wheezing (328)
Condition aggravated (325)
Thrombosis (274)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which DOXAZOSIN Alternatives Have Lower Salivary hypersecretion Risk?
DOXAZOSIN vs DOXAZOSIN\DOXAZOSIN
DOXAZOSIN vs DOXEPIN
DOXAZOSIN vs DOXERCALCIFEROL
DOXAZOSIN vs DOXIFLURIDINE
DOXAZOSIN vs DOXORUBICIN